Pfizer Adds Celebrex to Review

The countdown to Brandweek is on! Join us, Sept. 12-16, to identify new growth opportunities, solve challenges and connect with power players. View the lineup and secure your pass.

NEW YORK Pfizer is conducting a review for its Celebrex arthritis brand, now at J. Walter Thompson in New York, in addition to the three brands that are leaving Deutsch, sources said.

WPP Group’s JWT won Celebrex in July 2001, when the client shifted the $70 million account from Leo Burnett in Chicago.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in